(Q36365671)

13 August 2017

1 reference

title

The epidemiology of genital human papillomavirus infection (English)

1 reference

13 August 2017

1 reference

Eduardo L Franco

2

0 references

Helen Trottier

series ordinal

1

object named as

Helen Trottier

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

24 Suppl 1

1 reference

13 August 2017

page(s)

S1-15

1 reference

Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The epidemiology of human papillomavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiology of HPV infection among Mexican women with normal cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistent HPV infection in postmenopausal age women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The Role of Human Papillomaviruses in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiology of genital human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistence of type-specific human papillomavirus infection among cytologically normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Molecular Variant Analysis as an Epidemiological Tool to Study Persistence of Cervical Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Determinants of persistent detection of human papillomavirus DNA in the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Concurrent and sequential acquisition of different genital human papillomavirus types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Viral etiology of cervical cancer: a critique of the evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The causal relation between human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Do HPV-negative cervical carcinomas exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Carcinogenicity of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Epidemiology of Genital Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Determinants of Low-Risk and High-Risk Cervical Human Papillomavirus Infections in Montreal University Students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A stratified approach to untangling the behavioral/biomedical outcomes conundrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Partner type and condom use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Detection of human papillomavirus DNA on the fingers of patients with genital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Viral load as a predictor of the risk of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Polymorphisms of the Human Leukocyte Antigen DRB1 and DQB1 Genes and the Natural History of Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Human papillomavirus infection is transient in young women: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A population-based five-year follow-up study of cervical human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Clearance of HPV infection in middle aged men and women after 9 years' follow up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

Prospects for controlling cervical cancer at the turn of the century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.09.054

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.09.054

1 reference

13 August 2017

1 reference